{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:19:51Z","timestamp":1788830391559,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01718-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:54:09Z","timestamp":1751331249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying novel biomarkers for ankylosing spondylitis through proteomic profiling of serum-derived extracellular vesicles"],"prefix":"10.1007","volume":"25","author":[{"given":"Soo-Eun","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wook-Tae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-In","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Suk","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangbum","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hyeon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Soo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1718_CR1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379\u201390.","journal-title":"Lancet"},{"key":"1718_CR2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978\u201391.","journal-title":"Ann Rheum Dis"},{"key":"1718_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73\u201384.","journal-title":"Lancet"},{"key":"1718_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u201383.","journal-title":"Ann Rheum Dis"},{"key":"1718_CR5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/acr.24025","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, et al. 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71:1285\u201399.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1718_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1718_CR7","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.","journal-title":"J Extracell Vesicles"},{"key":"1718_CR8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40169-018-0192-7","volume":"7","author":"RE Lane","year":"2018","unstructured":"Lane RE, Korbie D, Hill MM, Trau M. Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges. Clin Transl Med. 2018;7:14.","journal-title":"Clin Transl Med"},{"key":"1718_CR9","doi-asserted-by":"crossref","first-page":"1359807","DOI":"10.3389\/fonc.2024.1359807","volume":"14","author":"Y Pei","year":"2024","unstructured":"Pei Y, Guo Y, Wang W, et al. Extracellular vesicles as a new frontier of diagnostic biomarkers in osteosarcoma diseases: a bibliometric and visualized study. Front Oncol. 2024;14:1359807.","journal-title":"Front Oncol"},{"key":"1718_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","volume":"77","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Schols M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77:3\u201317.","journal-title":"Ann Rheum Dis"},{"key":"1718_CR11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu W, He X, Cheng K, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 2019;7:22.","journal-title":"Bone Res"},{"key":"1718_CR12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12951-023-01921-3","volume":"21","author":"J Zhu","year":"2023","unstructured":"Zhu J, Wang S, Yang D, Xu W, Qian H. Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases. J Nanobiotechnol. 2023;21:164.","journal-title":"J Nanobiotechnol"},{"key":"1718_CR13","volume":"67","author":"E Zhou","year":"2021","unstructured":"Zhou E, Li Y, Wu F, et al. Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy. EBioMedicine. 2021;67: 103365.","journal-title":"EBioMedicine"},{"key":"1718_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12014-022-09354-0","volume":"19","author":"S Weiner","year":"2022","unstructured":"Weiner S, Sauer M, Visser PJ, et al. Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer\u2019s disease biomarkers. Clin Proteom. 2022;19:13.","journal-title":"Clin Proteom"},{"key":"1718_CR15","unstructured":"Wenker KJ, Quint JM. Ankylosing Spondylitis. In: StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Jessilin Quint declares no relevant financial relationships with ineligible companies. 2024."},{"key":"1718_CR16","doi-asserted-by":"crossref","unstructured":"Chee MM, Sturrock RD. Ankylosing spondylitis. Scott Med J. 2007;52:32\u20135; quiz 5, 54.","DOI":"10.1258\/rsmsmj.52.4.32"},{"key":"1718_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/13543784.10.1.21","volume":"10","author":"E Toussirot","year":"2001","unstructured":"Toussirot E, Wendling D. Therapeutic advances in ankylosing spondylitis. Expert Opin Investig Drugs. 2001;10:21\u20139.","journal-title":"Expert Opin Investig Drugs"},{"key":"1718_CR18","doi-asserted-by":"crossref","first-page":"1369116","DOI":"10.3389\/fimmu.2024.1369116","volume":"15","author":"Y Lai","year":"2024","unstructured":"Lai Y, Tang W, Luo X, et al. Gut microbiome and metabolome to discover pathogenic bacteria and probiotics in ankylosing spondylitis. Front Immunol. 2024;15:1369116.","journal-title":"Front Immunol"},{"key":"1718_CR19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10787-023-01331-9","volume":"32","author":"WW Buchanan","year":"2024","unstructured":"Buchanan WW, Kean CA, Rainsford KD, Kean WF. Spondyloarthropathies and arthritis post-infection: a historical perspective. Inflammopharmacology. 2024;32:73\u201381.","journal-title":"Inflammopharmacology"},{"key":"1718_CR20","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/cccp8o","author":"M Han","year":"2024","unstructured":"Han M, Ha JW, Jung I, Kim CY, Ahn SS. Association between Mycobacterium tuberculosis infection and the risk of inflammatory arthritides. Clin Exp Rheumatol. 2024. https:\/\/doi.org\/10.55563\/clinexprheumatol\/cccp8o.","journal-title":"Clin Exp Rheumatol"},{"key":"1718_CR21","first-page":"685","volume":"42","author":"A Albu","year":"2004","unstructured":"Albu A, Parasca I, Talu S, Poanta L. Ankylosing spondylitis\u2014a systemic disease. Rom J Intern Med. 2004;42:685\u201394.","journal-title":"Rom J Intern Med"},{"key":"1718_CR22","first-page":"S133","volume":"23","author":"J Zochling","year":"2005","unstructured":"Zochling J, Braun J. Assessment of ankylosing spondylitis. Clin Exp Rheumatol. 2005;23:S133\u201341.","journal-title":"Clin Exp Rheumatol"},{"key":"1718_CR23","first-page":"1635","volume":"121","author":"M Laitinen","year":"2005","unstructured":"Laitinen M, Hakala M. Ankylosing spondylitis. Duodecim. 2005;121:1635\u201342.","journal-title":"Duodecim"},{"key":"1718_CR24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00296-020-04600-w","volume":"40","author":"E Reilly","year":"2020","unstructured":"Reilly E, Sengupta R. Back pain, ankylosing spondylitis and social media usage; a descriptive analysis of current activity. Rheumatol Int. 2020;40:1493\u20139.","journal-title":"Rheumatol Int"},{"key":"1718_CR25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.18502\/jovr.v16i3.9440","volume":"16","author":"N Ebrahimiadib","year":"2021","unstructured":"Ebrahimiadib N, Berijani S, Ghahari M, Pahlaviani FG. Ankylosing spondylitis. J Ophthalmic Vis Res. 2021;16:462\u20139.","journal-title":"J Ophthalmic Vis Res"},{"key":"1718_CR26","volume":"12","author":"YF Lai","year":"2021","unstructured":"Lai YF, Lin TY, Chien WC, et al. Uveitis as a risk factor for developing acute myocardial infarction in Ankylosing Spondylitis: a national population-based Longitudinal Cohort Study. Front Immunol. 2021;12: 811664.","journal-title":"Front Immunol"},{"key":"1718_CR27","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/rheumatology\/keaa692","volume":"60","author":"K Bengtsson","year":"2021","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Deminger A, et al. Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study. Rheumatology (Oxford). 2021;60:2725\u201334.","journal-title":"Rheumatology (Oxford)"},{"key":"1718_CR28","volume":"11","author":"S Wang","year":"2020","unstructured":"Wang S, Tsou HK, Chiou JY, Wang YH, Zhang Z, Wei JC. Increased risk of inflammatory bowel disease among patients with ankylosing spondylitis: a 13-year population-based Cohort Study. Front Immunol. 2020;11: 578732.","journal-title":"Front Immunol"},{"key":"1718_CR29","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/echo.13298","volume":"33","author":"HJ Hwang","year":"2016","unstructured":"Hwang HJ, Kim JI, Lee SH, Park CB, Sohn IS. Full-blown cardiac manifestations in ankylosing spondylitis. Echocardiography. 2016;33:1785\u20137.","journal-title":"Echocardiography"},{"key":"1718_CR30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/1117-1936.181413","volume":"16","author":"PO Ibinaiye","year":"2009","unstructured":"Ibinaiye PO, Salawu F. Pulmonary manifestations of ankylosing spondylitis treated as pulmonary tuberculosis: a case report and review of literature. Niger Postgrad Med J. 2009;16:274\u20136.","journal-title":"Niger Postgrad Med J"},{"key":"1718_CR31","first-page":"51","volume":"83","author":"S Erdes","year":"2011","unstructured":"Erdes S. Some aspects of pathogenesis of ankylosing spondylitis. Ter Arkh. 2011;83:51\u20136.","journal-title":"Ter Arkh"},{"key":"1718_CR32","volume":"80","author":"WH Tsai","year":"2024","unstructured":"Tsai WH, Lin YC, Lan SH, et al. Generation of induced pluripotent stem cells from an HLA-B27 positive ankylosing spondylitis patient with syndesmophyte formation. Stem Cell Res. 2024;80: 103508.","journal-title":"Stem Cell Res"},{"key":"1718_CR33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1039\/D4MO00076E","volume":"20","author":"L Li","year":"2024","unstructured":"Li L, Ding S, Wang W, et al. Serum metabolomics reveals the metabolic profile and potential biomarkers of ankylosing spondylitis. Mol Omics. 2024;20:505\u201316.","journal-title":"Mol Omics"},{"key":"1718_CR34","volume":"16","author":"P Agrawal","year":"2024","unstructured":"Agrawal P, Tote S, Sapkale B. Diagnosis and treatment of ankylosing spondylitis. Cureus. 2024;16: e52559.","journal-title":"Cureus"},{"key":"1718_CR35","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC\/2008\/24\/1\/E2","volume":"24","author":"E Dakwar","year":"2008","unstructured":"Dakwar E, Reddy J, Vale FL, Uribe JS. A review of the pathogenesis of ankylosing spondylitis. Neurosurg Focus. 2008;24:E2.","journal-title":"Neurosurg Focus"},{"key":"1718_CR36","doi-asserted-by":"crossref","first-page":"2924935","DOI":"10.1155\/2021\/2924935","volume":"2021","author":"J Wielinska","year":"2021","unstructured":"Wielinska J, Crossland RE, Lacina P, et al. Exploring the extracellular vesicle MicroRNA expression repertoire in patients with rheumatoid arthritis and ankylosing spondylitis treated with TNF inhibitors. Dis Markers. 2021;2021:2924935.","journal-title":"Dis Markers"},{"key":"1718_CR37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/cbin.11760","volume":"46","author":"L Zhang","year":"2022","unstructured":"Zhang L, Qu L, Zhang Y, Xu Z, Tang H. Differential expression of circular RNAs in plasma exosomes from patients with ankylosing spondylitis. Cell Biol Int. 2022;46:649\u201359.","journal-title":"Cell Biol Int"},{"key":"1718_CR38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrm1130","volume":"4","author":"R Timpl","year":"2003","unstructured":"Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol. 2003;4:479\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1718_CR39","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.1007\/s11033-020-05938-x","volume":"47","author":"M Hedayati","year":"2020","unstructured":"Hedayati M, Abooshahab R, Razavi SA, Salehipour P, Ahmadikia K, Boroomand S. Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review. Mol Biol Rep. 2020;47:8859\u201366.","journal-title":"Mol Biol Rep"},{"key":"1718_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5482\/HAMO-16-06-0018","volume":"37","author":"MA Brehm","year":"2017","unstructured":"Brehm MA. Von Willebrand factor processing. Hamostaseologie. 2017;37:59\u201372.","journal-title":"Hamostaseologie"},{"key":"1718_CR41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","volume":"132","author":"AM Randi","year":"2018","unstructured":"Randi AM, Smith KE, Castaman G. von Willebrand factor regulation of blood vessel formation. Blood. 2018;132:132\u201340.","journal-title":"Blood"},{"key":"1718_CR42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bjh.16681","volume":"191","author":"H Fogarty","year":"2020","unstructured":"Fogarty H, Doherty D, O\u2019Donnell JS. New developments in von Willebrand disease. Br J Haematol. 2020;191:329\u201339.","journal-title":"Br J Haematol"},{"key":"1718_CR43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10067-011-1760-z","volume":"31","author":"A Taylan","year":"2012","unstructured":"Taylan A, Sari I, Kozaci DL, et al. Evaluation of various endothelial biomarkers in ankylosing spondylitis. Clin Rheumatol. 2012;31:23\u20138.","journal-title":"Clin Rheumatol"},{"key":"1718_CR44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","volume":"56","author":"C Skerka","year":"2013","unstructured":"Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT. Complement factor H related proteins (CFHRs). Mol Immunol. 2013;56:170\u201380.","journal-title":"Mol Immunol"},{"key":"1718_CR45","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/jcm10081744","volume":"10","author":"K Los","year":"2021","unstructured":"Los K, Waszkiewicz N. Biological markers in anxiety disorders. J Clin Med. 2021;10:1744.","journal-title":"J Clin Med"},{"key":"1718_CR46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2169\/internalmedicine.49.3193","volume":"49","author":"H Ishii","year":"2010","unstructured":"Ishii H, Iwata A, Oka H, Sakamoto N, Ishimatsu Y, Kadota J. Elevated serum levels of lysozyme in desquamative interstitial pneumonia. Intern Med. 2010;49:847\u201351.","journal-title":"Intern Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01718-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01718-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01718-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:51:21Z","timestamp":1764917481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01718-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1718"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01718-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5921683\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}